Home Latest Articles
Latest Articles
  • Min CHEN, Duopeng CHEN, Qixing LIU, Yiwen LIU, Haifeng ZHOU
    Chinese Journal of Pharmaceuticals. 2025, 56(2): 187-189.

    The synthesis process of trimetazidine hydrochloride(1) was improved in this study. Trimetazidine(5) was prepared from inexpensive and widely available 2,3,4-trimethoxybenzaldehyde(2) and anhydrous piperazine(3) via reductive amination and hydrolysis with formic acid as hydrogen source and commercially available pyridinamide iridium complex(4) as catalyst, which was further treated with hydrogen chloride to provide trimetazidine dihydrochloride(1) with 99.8% purity and 75.5% total yield (based on 2). This improved process has the advantages of mild reaction conditions, low catalyst loading(0.01% of mole fraction), high yield, less consumption of 3 and formic acid and low cost.

  • Zhongsong ZHU, Wei PENG, Zhong LIU, Guimin ZHANG, Lili ZHAO
    Chinese Journal of Pharmaceuticals. 2025, 56(2): 190-197.

    The Claudin18.2 antibody holds significant potential in the treatment of gastric carcinoma. However, due to its non-human sequence and relatively weak receptor affinity, the efficacy and safety of the marketed antibodies still need to be improved. Through hybridoma screening, antibody humanization and modification of antibody-dependent cell-mediated cytotoxicity(ADCC), this study obtained the monoclonal antibody, named 110E2A4-M2, that specifically binds to Claudin18.2. Subsequently, the ADCC and complement-dependent cytotoxicity(CDC) activities of the antibody were determined, and its pharmacological effects were studied in a mouse xenograft tumor model. The results showed that the ADCC activity of 110E2A4-M2 was significantly higher than that of the control antibody(IMAB362), and its CDC activity was not reduced. It displayed a relatively strong tumor-suppressing ability in the mouse subcutaneous xenograft tumor model, with a tumor growth inhibition rate of 52.35%. This study provided data support for the development of Claudin18.2 antibodies.

  • Xiu ZHANG, Li ZHANG, Xiaoyuan LI, Shijing DU, Zhenghuai TAN
    Chinese Journal of Pharmaceuticals. 2025, 56(2): 198-204.

    Thrombolytic enzyme AprE9912D(AprE), an alkaline protease secreted by Bacillus velezensis 9912D, shows fibrinolytic activity. The purification process of AprE was determined by comparing yields, purification levels and other parameters of soluble protein and inclusion body for the following experiment. After purification, thrombolytic effect, hemolytic property and characterization of AprE was explored in vitro. Compared with the purification of AprE from the soluble protein, AprE in inclusion body was obtained through washing, rapid dialysis renaturation, anion-exchange chromatography column with purity of over 95%, renaturation rate of 52.7%, yield of 11.2%, and higher specific enzyme activity(50 456.7 IU/mg). Therefore, it was appropriate to express AprE in the form of inclusion bodies. In vitro, 10 000 IU/mL of AprE could significantly dissolve old thrombi, the thrombolysis rate was 16.7%(P<0.001). The hemolysis rate of AprE at a concentration of 2 000 IU/mL was only 1.0%, indicated good safety. The optimal temperature and pH value for the reaction of AprE were 35 - 45 ℃ and 7.0 - 8.0, respectively. This study provided a scientific basis for the future research of the natural thrombolytic enzyme AprE.

  • Mengru XIN, Di XIE, Weidong MAO, Li ZHOU, Shan GUO, Hankun HU
    Chinese Journal of Pharmaceuticals. 2025, 56(2): 205-216.

    Cultured Cordyceps sinensis(CCs) possesses similar chemical components and pharmacological activities to wild Chinese cordyceps. However, the synergistic effects of multiple chemical components on disease-preventative potentials remain unexplored. This study utilized multi-omics technologies, including LC-MS/MS-based metabolomics, proteomics, and transcriptomics, to comprehensively explore the systemic biological responses of healthy rats after irrgation of CCs for 14 days. After LC-MS measurement, 993 of water-soluble metabolites and 804 of fat-soluble metabolites were identified in homogenized CCs. Furthermore, significant differences were observed between the Rats +CCs group and the Rats + normal saline group(the control). There were 293 differential metabolites out of 2 711 metabolites measured in blood plasma, and 38 differential proteins among 782 proteins detected in blood plasma. The majority of differential metabolites were lipids, mainly glyceryl esters(e.g., monoglyceride, diglyceride, and triglyceride). Additionally,147 differentially expressed genes(DEGs) were identified from the transcriptomic data of blood cells. Subsequently, through annotation in the Kyoto Encyclopedia of Genes and Genomes(KEGG) database, differential metabolites, proteins, and DEGs were enriched in body metabolism-associated pathways(e.g., metabolic pathways, glycerolipid metabolism, and cholesterol metabolism) and immune-related disease pathways(e.g., coronavirus disease pathway, NK cell-mediated cytotoxicity pathway, NF-κB signaling pathway, and hepatocellular carcinoma pathway). This is the first molecular-level evidence confirming that consuming CCs has the potential to regulate body metabolism and immune defense.

  • Shoude ZHANG, Guowei ZHAO, Meng LIU, Teng AO, Tangde FENG
    Chinese Journal of Pharmaceuticals. 2025, 56(2): 217-223.

    The andrographolide solid dispersions with Soluplus® as a carrier were prepared by spray drying method. The hygroscopicity, intermolecular interaction, thermal stability, relative crystallinity, and dissolution behavior of the solid dispersions were used as evaluation indicators to investigate the storage stability of the products under different temperature[(40±2) and (60±2)℃] and relative humidity[(55±5)%, (75±5)% and (95±5)%] conditions. The results indicated that the hygroscopicity, intermolecular interaction, thermal stability, and relative crystallinity of andrographolide solid dispersions were significantly altered by the effects of temperature and relative humidity, which in turn led to a decrease in dissolution rate and dissolution. The results of dissolution in vitro also showed that under the storage condition of (40±2)℃, although the dissolution of solid dispersion decreased with the increasing of relative humidity, it still had a solubilization advantage compared to the bulk drug. However, under the storage condition of (60±2)℃, even with a relative humidity(55%), the dissolution of the solid dispersions had decreased to a level similar to that of API, indicating that the solubilization advantage of solid dispersion was completely destroyed. These results showed that high temperature had a more significant impact on the dissolution stability of andrographolide solid dispersions. Therefore, this product should be stored in an environment with a temperature of no more then (40±2)℃ and a relative humidity of no more then(55±5)%.

  • Yuhan GUO, Yan ZHENG, Yunhui XU, Jing ZHOU, Lijuan YAO, Moli HUA
    Chinese Journal of Pharmaceuticals. 2025, 56(2): 224-231.

    A quantitative nuclear magnetic resonance spectroscopy(1H qNMR) method was established for the determination of Δ9-trans-tetrahydrocannabinol(1) and Δ9-cis-tetrahydrocannabinol(2) from hemp, and the methodology was verified. The results showed that when the concentration of 1 and 2 were 5.133×10–2 - 20.53 and 5.033×10–2 -2.013 mg/mL, respectively, a good linear relationship was observed between the concentration and the characteristic peak area(r>0.999). And the precision RSD was 0.97% and 1.83%, respectively. The average recoveries were 96.89% and 97.88%, with the RSDs of 2.96% and 3.08%, respectively. The limits of quantitation were 0.513 3 and 0.050 3 mg/mL, respectively. The method was accurate and reliable. Compared with the HPLC and LC-MS/MS methods, the sensitivity of 1H qNMR method was 3 - 5 orders of magnitude low. Meanwhile, the results of 1H qNMR and HPLC were basically consistent. The results indicate that the 1H qNMR method developed in this study can be used for rapid identification and quantification of 1 and 2 , which provides the technical support for quality control and pharmaceutical development of Δ9-THC from hemp.

  • Xia LING, Shiying SONG, Xiaoxia YE, Ye ZHANG, Xu XU, Jian LE
    Chinese Journal of Pharmaceuticals. 2025, 56(2): 232-238.

    A method for determining the in vitro release of tacrolimus(1) ointment was established using an improved Franz diffusion cell, and the consistency of in vitro release of 1 ointments with the same specifications but different prescription processes was evaluated. Firstly, the median in vitro release rate ratio of the original formulations, 1 0.1% and 0.03% ointment, was calculated. The results showed that the 90% confidence intervals were within the limit range of 75.00% to 133.33% specified by the FDA for consistency. Then, the median in vitro release rate ratios of 1 0.1% ointment generic drugs from 6 manufacturers to original reference formulation were calculated. The results showed that the 90% confidence intervals of samples C and F were within the specified limits, while samples D, E, G, and H did not fall within the specified limits. The established method met the requirements for in vitro release evaluation of 1 ointment, and the evaluation method could effectively distinguish different production processes of manufacturers.

  • Juan QIU, Bishan ZHANG, Weiling LI
    Chinese Journal of Pharmaceuticals. 2025, 56(2): 239-243.

    In order to better control the quality of dioxopromethazine hydrochloride(1) granules, a HPLC method for determination of the related substances was established with the reference to Chinese Pharmacopoeia 2020 Edition. The Phenomenex Luna C18 column(4.6 mm×250 mm, 5 μm) was used, with the mobile phase of ammonium acetate buffer solution-acetonitrile(75∶25). The flow rate was 1.0 mL/min, the detection wavelength was 264 nm, and the column temperature was 30 ℃. The results showed that the total amount of related substances in the 14 batches of samples was in the range of 0.3% to 2.3%. This study provided a reference for more effectively controlling the quality of 1 granules and improving quality standards for other drugs.

  • Jing REN
    Chinese Journal of Pharmaceuticals. 2025, 56(2): 244-248.

    An HPLC method was established for simultaneous determination of 8 antioxidants and their degradtion products in the extracts from polypropylene ampoule packaging and their migration in the inhalation suspension of fluticasone propionate(1). The Poroshell 120 EC-C18 column(4.6 mm×50 mm, 2.7 μm) was used, and the analysis was carried out in the gradient elution mode with 0.2% acetic acid as mobile phase A, isopropanol as mobile phase B, and acetonitrile as mobile phase C. The flow rate was 1.0 mL/min, the detection wavelength was 280 nm, and the column temperature was 40 ℃. The results showed that it was linear for 8 antioxidants and their degradation products in the range of 0.25 - 50 μg/mL. The detection limit was 0.10 μg/mL, the quantification limit was 0.25 μg/mL, and the spiked recovery rate were between 80.8% and 109.9%. The recovery rates in pH 3.5 buffer, pH 8.0 buffer, 0.9% sodium chloride solution, and 50% isopropanol medium were all between 95.2% and 107.7%, with RSDs ranging from 0.1% to 2.2%. The established method is easy to operate, with good accuracy and repeatability, which provide a reference for the quality control research of 1 inhalation suspension.

  • Tao HU, Yan SHENG, Zhenzhen ZHANG, Jinfeng LIANG
    Chinese Journal of Pharmaceuticals. 2025, 56(2): 249-257.
News